L 759274
Alternative Names: NK1 antagonist - Merck; Substance P antagonist - MerckLatest Information Update: 20 Jun 2012
At a glance
- Originator Merck & Co
- Class Antidepressants
- Mechanism of Action Neurokinin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder